Cybin (OTCMKTS:CLXPF) Trading 12.5% Higher - What's Next?

Key Points

• Cybin Inc. shares surged 12.5% to $6.73 during mid-day trading, with a trading volume increase of 37% compared to the average daily volume.
• The company has a market capitalization of $1.00 billion and a negative price-to-earnings ratio of -28.04, indicating challenges in profitability.
• Cybin focuses on developing psychedelic therapeutics for various psychiatric and neurological conditions, operating through its Serenity Life and Natures Journey segments.

Cybin Inc. (OTCMKTS:CLXPF - ) shares traded up 12.5% during mid-day trading on Monday . The company traded as high as $6.73 and last traded at $6.73. 754,673 shares were traded during mid-day trading, an increase of 37% from the average session volume of 551,962 shares. The stock had previously closed at $5.98.

Cybin Stock Performance

The business has a fifty day simple moving average of $7.48 and a 200-day simple moving average of $7.36. The firm has a market cap of $1.00 billion and a price-to-earnings ratio of -28.04.

About Cybin

Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.